<?xml version="1.0" encoding="UTF-8"?>
<ref id="B151-microorganisms-08-01017">
 <label>151.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Herold</surname>
    <given-names>K.C.</given-names>
   </name>
   <name>
    <surname>Bundy</surname>
    <given-names>B.N.</given-names>
   </name>
   <name>
    <surname>Long</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Bluestone</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>DiMeglio</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Dufort</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Gitelman</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Gottlieb</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Krischer</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Linsley</surname>
    <given-names>P.S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2019</year>
  <volume>381</volume>
  <fpage>603</fpage>
  <lpage>613</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1902226</pub-id>
  <?supplied-pmid 31180194?>
  <pub-id pub-id-type="pmid">31180194</pub-id>
 </element-citation>
</ref>
